Clinical Trials Directory

Trials / Completed

CompletedNCT07454876

Association of TLR7 Gene rs3853839 Polymorphism With Disease Severity in Alopecia Areata: A Case-Control Study

Association Between Toll Like Receptor- 7 Gene Polymorphism and Alopecia Areata

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Alopecia areata is an autoimmune, non-scarring hair loss disorder characterized by variable clinical severity. Toll-like receptor 7 (TLR7) plays a key role in innate immune activation and autoimmune responses. The rs3853839 polymorphism of the TLR7 gene has been implicated in immune-mediated diseases. This study aims to evaluate the association between TLR7 rs3853839 polymorphism and susceptibility to alopecia areata, and to assess its correlation with disease severity measured by the Severity of Alopecia Tool (SALT) score. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

Conditions

Timeline

Start date
2022-12-01
Primary completion
2023-12-10
Completion
2023-12-12
First posted
2026-03-06
Last updated
2026-03-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07454876. Inclusion in this directory is not an endorsement.